Connect with us

Hi, what are you looking for?

Politics

U.S. lawmakers intensify bipartisan efforts to counter China

Politics1 hour ago (Apr 21, 2021 02:30PM ET)

(C) Reuters. FILE PHOTO: Chinese and U.S. flags flutter outside the building of an American company in Beijing

By Patricia Zengerle and Michael Martina

WASHINGTON (Reuters) -A bipartisan U.S. congressional push to counteract China picked up steam on Wednesday as a Senate committee overwhelmingly backed a bill pressing Beijing on human rights and economic competition and other lawmakers introduced a measure seeking billions for technology research.

The Senate Foreign Relations Committee backed the “Strategic Competition Act of 2021” by 21-1, sending the bill for a vote in the 100-member Senate, even as they voiced a need to do even more to counteract Beijing.

Separately, a group of Senate and House of Representatives lawmakers introduced the “Endless Frontier Act,” calling for $100 billion over five years for basic and advanced technology research and $10 billion to create new “technology hubs” across the country.

Both bills have strong support from both political parties and are expected to eventually become law. The desire for a hard line in dealings with China is one of the few truly bipartisan sentiments in the deeply divided U.S. Congress, which is narrowly controlled by President Joe Biden’s fellow Democrats.

The Biden administration supports many provisions of the measures.

“This is a challenge of unprecedented scope, scale and urgency, and one that demands a policy and strategy that is genuinely competitive,” said Senator Bob Menendez, the Democratic chairman of the Senate panel.

He and Senator Jim Risch, the panel’s top Republican, wrote the “Strategic Competition” measure together, with Risch telling members it was “truly bipartisan.”

HUMAN RIGHTS AND MILITARY SPENDING

The 280-page Senate bill addresses competition with China through efforts such as increasing international development funding. It pushes humanitarian and democratic values, like imposing sanctions over the treatment of the minority Muslim Uighurs and supporting democracy in Hong Kong. [L1N2M113C]

The bill stresses the need to “prioritize the military investments necessary to achieve United States political objectives in the Indo-Pacific.” It recommends a total of $655 million in Foreign Military Financing funding for the Indo-Pacific region for fiscal 2022 through 2026, and a total of $450 million for the Indo-Pacific Maritime Security Initiative and related programs for the same period.

It would expand the scope of the Committee on Foreign Investment in the United States (CFIUS), which scrutinizes financial transactions for potential national security risks.

The two measures are part of a fast-track effort announced in February by Democratic Senate Majority Leader Chuck Schumer to pass a wide range of legislation to counter China. Schumer is a lead sponsor of the Endless Frontier bill.

Foreign Relations committee members said they want to do more.

“I don’t believe anyone would think that this legislation is going to change China’s march toward a global hegemony of autocracy and repression,” Republican Senator Mitt Romney said. “…I would suggest we have a lot more work to do.”

Eric Sayers, who studies technology policy and U.S. defense strategy in the Asia-Pacific at the conservative-leaning American Enterprise Institute, called the legislation an important part of efforts to address challenges posed by China.

The proposed spending builds on earlier legislation “taking a bold step in the technology competition with China through investing in our domestic competitiveness and building new resilience in our supply chains,” Sayers said.

U.S. lawmakers intensify bipartisan efforts to counter China

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Uncategorized

Neque porro quisquam est, qui dolorem ipsum quia dolor sit amet, consectetur, adipisci velit, sed quia non numquam eius modi tempora incidunt.

Uncategorized

Nemo enim ipsam voluptatem quia voluptas sit aspernatur aut odit aut fugit, sed quia consequuntur magni dolores eos qui ratione.

Uncategorized

Quis autem vel eum iure reprehenderit qui in ea voluptate velit esse quam nihil molestiae consequatur, vel illum qui dolorem eum.

Uncategorized

Neque porro quisquam est, qui dolorem ipsum quia dolor sit amet, consectetur, adipisci velit, sed quia non numquam eius modi tempora.

Disclaimer: Buzzclever.com it's managers and its employees (collectively "The Company") do not make any guarantee or warranty about what is advertised or above. Information provided by this website is for research purposes only and should not be considered as personalized financial or health advice. Copyright © 2021 Buzz Clever. All Rights Reserved